Biologic Induction Agents

Biologic Induction Agents is a class of therapeutic biologics, primarily monoclonal antibodies or fusion proteins, that selectively target immune cell components or signaling pathways to achieve rapid and potent immunosuppression during the induction phase of transplant rejection prophylaxis.

55

Publications

2.8K

Citations

334

Authors

137

Institutions

Publications per year

2017–2026

11

Authors

334

  1. SF
    Stefano Faenza

    University of Bologna, Italy

    2 publications · 28 citations

    2

    h-index

  2. DH
    Don Hayes

    The Ohio State University, United States

    2 publications · 76 citations

    2

    h-index

  3. AW
    Allison Wehr

    The Ohio State University, United States

    2 publications · 76 citations

    2

    h-index

  4. JW
    JOHN W. DUNDEE

    Queen's University Belfast, United Kingdom

    2 publications · 136 citations

    2

    h-index

  5. RD
    Richard D. Gelber

    Dana-Farber Cancer Institute, United States

    2 publications · 154 citations

    2

    h-index

1–5 of 334

Venues

  1. Transplantation

    9 publications · 905 citations

    9

    h-index

  2. Clinical Transplantation

    3 publications · 97 citations

    3

    h-index

  3. PubMed

    Repository · 3 publications · 55 citations

    3

    h-index

  4. Pediatric Transplantation

    3 publications · 55 citations

    3

    h-index

  5. Nephrology Dialysis Transplantation

    NDT · 3 publications · 80 citations

    3

    h-index

1–5